Net Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2022

Antidilutive Shares Excluded from Computation of Diluted Net Income (Loss) Per Share

The following outstanding shares subject to stock options and RSUs, warrants to purchase shares of common stock, common stock issuable upon conversion of convertible debt and shares issuable under the Company’s employee stock purchase plan were antidilutive due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the three months ended March 31, 2022 and 2021 as indicated below:


	March 31,
	2022	2021
Excluded potentially dilutive securities (1):
Common stock issuable under outstanding convertible notes	10,377,361	10,377,361
Shares subject to outstanding options to purchase common stock	2,163,682	2,155,199
Unvested restricted stock units	7,071,933	6,471,549
Shares subject to warrants to purchase common stock	432,240	479,002
Shares issuable under employee stock purchase plan	459,870	606,816
Totals	20,505,086	20,089,927

(1)The number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as of March 31, 2022 and 2021. Such amounts have not been adjusted for the treasury-stock method or weighted-average outstanding calculations as required if the securities were dilutive.